Health Condition 1: null- HIV-infected women
Conditions
Interventions
Intervention1: Cervical cancer screening of all enrolled women using VIA, VILI, cytology and HPV testing: Eligible HIV-infected women were screened using multiple screening tests to detect CIN. All wo
Sponsors
Prayas
Eligibility
Inclusion criteria
Inclusion criteria: 1. HIV-infected women 2. Willing to sign an informed consent form 3. Having an intact uterus
Exclusion criteria
Exclusion criteria: 1. Women who have undergone hysterectomy 2. Women having a debilitating health condition 3. Women with prior history of any procedure on the cervix
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Effectiveness of cold coagulation in curing and preventing recurrence of CIN 2-3 lesions in HIV-infected womenTimepoint: Initially after 6 months and then every year thereafter | — |
Primary
| Measure | Time frame |
|---|---|
| 1. Test performance of cytology, VIA, VILI and HPV testing to detect CIN 2-3 lesions 2. Prevalence and type distribution of high-risk HPV types in HIV-infected women and its correlation with cervical abnormalities 3. Distribution of HPV types in CIN and in cervical cancer specimens in HIV-infected Timepoint: Baseline at screening | — |
Countries
India
Contacts
Public ContactDr Smita Joshi
Prayas and HCJMRI & JCDC, Jehangir Hospital Pune
Outcome results
None listed